Poland at a glance
- Population
- 36.4 million 2025
- Life expectancy at birth
- 78.4 years, 2024
- People aged 65 and over
- 20.8 % of people, 2025
- Health spending per person
- 2,014 US$ per person, 2024
- Doctors
- 4.03 per 1,000 people, 2023
Updated
Reviewed by Chandani Patel
Poland Pharmaceuticals Market Industry Trends and Forecast to 2034: Segmented by (Product, Route, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$5.77 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $10.77 Bn | — | — |
| 2025 (base) | $11.28 Bn | +$506.2 Mn | — |
| 2026 (forecast) | $11.81 Bn | +$529.9 Mn | +4.7% |
| 2027 (forecast) | $12.36 Bn | +$554.9 Mn | +9.6% |
| 2028 (forecast) | $12.94 Bn | +$580.9 Mn | +14.8% |
| 2029 (forecast) | $13.55 Bn | +$608.2 Mn | +20.2% |
| 2030 (forecast) | $14.19 Bn | +$636.8 Mn | +25.8% |
| 2031 (forecast) | $14.85 Bn | +$666.8 Mn | +31.7% |
| 2032 (forecast) | $15.55 Bn | +$698.1 Mn | +37.9% |
| 2033 (forecast) | $16.28 Bn | +$730.9 Mn | +44.4% |
| 2034 (forecast) | $17.05 Bn | +$765.3 Mn | +51.2% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $11.28 Bn placeholder estimate |
|---|---|
| Forecast, 2034 | $17.05 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 4.7% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, route and end user (see all) |
| Key players | Pfizer Inc., Johnson & Johnson, Roche, Novartis AG, Merck & Co., Inc. and 1 more (see all) |
| Regulator in Poland | URPLSource: Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (URPL). Checked 19 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Pharmaceuticals are the medicines, branded and generic, that prevent, treat and cure disease in people.
Key segments of the pharmaceuticals market include product (Branded Drugs, Generic Drugs and Biologics) and route (Oral, Injectable and Topical).
Ageing populations, more chronic disease, broader access to medicines and steady new drug approvals are driving the pharmaceuticals market.
Personalized treatments, local manufacturing and new technologies for making medicines give the pharmaceuticals market room to grow.
Price controls, long and costly development, patent expiries and strict quality rules hold back the pharmaceuticals market.
The pharmaceuticals market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medicines are authorised either for the whole EU by the European Commission, after review by the European Medicines Agency (EMA), or nationally by the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (URPL).[1] The National Health Fund (NFZ) pays for public care for insured people, and the Ministry of Health decides which medicines are reimbursed.[2]
[1] Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (URPL). Checked 19 Nov 2026.
[2] National Health Fund (NFZ). Checked 19 Nov 2026.
Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for pharmaceuticals. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Poland.
What doctors and scientists are doing in Pharmaceuticals right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 20 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 20 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 21 Nov 2026.
From our blog
Poland · 2 shared keywords
Poland · 1 shared keyword
Medical Devices · Poland
Medical Devices · Global
Healthcare Services · Global
Healthcare Services · Global
Healthcare Services · Global
Healthcare Services · Global